SecSonar.com

HCW Biologics Inc. (HCWB)

HCW Biologics Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

HCW Biologics Inc. (HCWB) is a Biotechnology company based in US with a market capitalization of $4.3M. Revenue declined 97.9% year-over-year and free cash flow was negative at -$13.4M. This page tracks HCWB's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 36 employees · IPO Jul 20, 2021

Valuation

Valuation & price

$1.22 · as of May 17, 2026 · -96.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.55

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$36.12$18.86$1.61Jul 25Dec 25Jul 26Jul 7, 25$25.02Jul 9, 25$25.92Jul 11, 25$26.10Jul 15, 25$26.16Jul 17, 25$28.26Jul 21, 25$26.82Jul 23, 25$26.52Jul 25, 25$25.56Jul 29, 25$26.46Jul 31, 25$25.44Aug 4, 25$25.20Aug 6, 25$27.12Aug 11, 25$27.84Aug 13, 25$26.94Aug 15, 25$24.54Aug 19, 25$21.36Aug 21, 25$19.86Aug 25, 25$33.30Aug 27, 25$36.12Aug 29, 25$34.32Sep 3, 25$28.80Sep 5, 25$25.44Sep 9, 25$21.30Sep 11, 25$19.92Sep 16, 25$24.90Sep 18, 25$27.24Sep 22, 25$24.24Sep 24, 25$24.84Sep 26, 25$24.54Sep 30, 25$22.20Oct 2, 25$22.38Oct 6, 25$24.18Oct 8, 25$29.28Oct 10, 25$24.36Oct 14, 25$27.00Oct 16, 25$24.12Oct 21, 25$23.70Oct 23, 25$23.40Oct 27, 25$23.10Oct 29, 25$23.10Oct 31, 25$23.22Nov 4, 25$20.40Nov 6, 25$19.92Nov 10, 25$18.36Nov 12, 25$15.60Nov 14, 25$18.00Nov 18, 25$14.46Nov 20, 25$11.52Nov 25, 25$11.52Nov 28, 25$12.72Dec 2, 25$11.94Dec 4, 25$12.24Dec 8, 25$11.82Dec 10, 25$12.00Dec 12, 25$10.86Dec 16, 25$10.68Dec 18, 25$9.78Dec 22, 25$9.36Dec 24, 25$8.94Dec 29, 25$7.50Jan 2, 26$6.72Jan 6, 26$7.20Jan 8, 26$7.32Jan 12, 26$7.32Jan 14, 26$6.90Jan 16, 26$8.28Jan 21, 26$7.98Jan 23, 26$8.10Jan 27, 26$7.62Jan 29, 26$6.84Feb 2, 26$6.96Feb 4, 26$6.30Feb 9, 26$6.30Feb 11, 26$5.94Feb 13, 26$3.90Feb 18, 26$3.55Feb 20, 26$3.47Feb 24, 26$3.41Feb 26, 26$3.30Mar 2, 26$3.30Mar 4, 26$3.94Mar 6, 26$3.72Mar 10, 26$3.37Mar 12, 26$3.35Mar 17, 26$5.26Mar 19, 26$4.51Mar 23, 26$3.11Mar 25, 26$2.34Mar 27, 26$2.39Mar 31, 26$2.16Apr 2, 26$1.61Apr 7, 26$1.64Apr 9, 26$2.02Apr 13, 26$2.11Apr 15, 26$2.44Apr 17, 26$2.62Apr 22, 26$2.39Apr 24, 26$2.25Apr 28, 26$2.40Apr 30, 26$2.83May 4, 26$2.46May 6, 26$2.10May 8, 26$1.97May 12, 26$2.04May 14, 26$2.02May 18, 26$8.04May 20, 26$14.58May 22, 26$17.34May 28, 26$12.54Jun 1, 26$12.42Jun 3, 26$10.08Jun 5, 26$9.78Jun 9, 26$7.08Jun 11, 26$7.92Jun 15, 26$7.32Jun 17, 26$6.60Jun 22, 26$6.96Jun 24, 26$6.66Jun 26, 26$6.18Jul 2, 26$4.30
$1.6152-week range$36.12
Loading valuation history…

Fundamentals

Key fundamentals

$4.3M

Market cap

-97.9%

Revenue growth (YoY)

20.0%

Gross margin

-$13.4M

Free cash flow (USD)

$4.9M

Net debt

-94.6%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$0.00FY 2020$4.1MFY 2021$0.00FY 2022$6.7MFY 2023$2.8MFY 2024$2.6MFY 2025$54.2K
$0$54.2K

Free cash flow by year

2019 → 2025

FY 2019$-8.2MFY 2020$-10.6MFY 2021$-11.0MFY 2022$-20.7MFY 2023$-28.7MFY 2024$-14.5MFY 2025$-13.4M
-$8.2M-$13.4M

Gross margin by year

2022 → 2025

FY 202238.5%FY 202319.7%FY 202437.4%FY 202520.0%
38.5%20.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

3

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 14, 2026 (EPS $0.37)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventSettlement Agreement CompletedJul 1, 2026Filing
  • 8-K eventRegained ComplianceJun 30, 2026Filing
  • 8-K eventReverse Stock SplitJun 26, 2026Filing
  • 8-K eventClinical Trial ResultsJun 16, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 15, 2026Filing
  • 8-K eventDelisting NoticeJun 1, 2026Filing
  • Insider buyInsider Buy $20KByam Rebecca · Chief Financial Officer · $20KMay 27, 2026Filing
  • Insider buyInsider Buy $250KGARRETT SCOTT T · Director · $250KMay 27, 2026Filing
  • Insider buyInsider Buy $160KWong Hing C · Director, Chief Executive Officer, 10% Owner · $160KMay 27, 2026Filing
  • 8-K eventLicense Agreement TerminationMay 27, 2026Filing

Questions

Frequently asked questions

What is HCW Biologics Inc.'s market cap?

HCW Biologics Inc. (HCWB) has a market capitalization of $4.3M.

What is HCWB's P/E ratio?

A meaningful P/E ratio is not available for HCWB — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is HCWB's price-to-book (P/B) ratio?

HCWB trades at 1.55 times book value per share.

When did HCW Biologics Inc. last report earnings?

HCWB last reported earnings on May 14, 2026; the next date is not yet scheduled.

Are insiders buying HCWB stock?

Yes — SEC Form 4 filings show 3 open-market insider buys and 0 sells at HCW Biologics Inc. in the last 90 days.

Same arena

Related companies in Biotechnology

MTNB

Matinas BioPharma Holdings, Inc.

$4.5M

BRTX

BioRestorative Therapies, Inc.

$4.6M

CDIO

Cardio Diagnostics Holdings, Inc.

$3.7M

SILO

Silo Pharma, Inc.

$3.6M

ADXN

Addex Therapeutics Ltd

$5M

CLGN

CollPlant Biotechnologies Ltd.

$5M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.